- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 2.8 Agreement and Plan of Merger
- 10.63 Change In Control Agreement
- 10.64 Change-in-control Agreement
- 10.65 Change-in-control Agreement
- 10.66 Amended and Restated Change-in-control Agreement
- 10.67 Amended and Restated Change-in-control Agreement
- 10.68 Amended and Restated Chage-in-control Agreement
- 10.69 Amended and Restated Change-in-control Agreement
- 10.70 Restated Stock Agreement
- 10.71 Restricted Stock Agreement
- 14.1 Invitrogen Protocol
- 21.1 List of Subsidiaries
- 23.1 Consent of Ernst & Young, LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
Exhibit 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements on Form S-3 (nos. 333-84134, 333-37964 , 333-52896 and 333-110060), Form S-4 (nos. 333-4374 and 333-82593), and Form S-8 (nos. 333-46146, 333-36606, 333-86531, 333-74061, 333-105730, 333-108291, 333-108442 and 333-112495) of Invitrogen Corporation and in the related Prospectus of our report dated February 5, 2004, except with respect to Note 4 thereto, as to which the date of our report is February 19, 2004, with respect to the consolidated financial statements and schedule of Invitrogen Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2003.
ERNST & YOUNG LLP
San Diego, California
February 26, 2004